SCHEMBL2740990

SCHEMBL2740990

O=[N+]([O-])c1ccc(N/N=C/c2ccc(O)cc2)c(S(=O)(=O)Nc2ccccc2Cl)c1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ L3MBTL1 Q9Y468 3/20 0.57
▸ PSMD14 O00487 2/20 0.57
▸ ALPL P05186 1/20 0.57
▸ ALPI P09923 1/20 0.57
▸ ALPG P10696 1/20 0.57
▸ MEN1 O00255 10/20 0.55
▸ KMT2A Q03164 10/20 0.55
▸ MAPT P10636 9/20 0.55
▸ HTT P42858 4/20 0.55
▸ NPC1 O15118 4/20 0.55
▸ RAB9A P51151 4/20 0.55
▸ GAA P10253 4/20 0.55
▸ SMN1; SMN2 Q16637 3/20 0.55
▸ XBP1 P17861 1/20 0.55
▸ NPSR1 Q6W5P4 2/20 0.51
▸ ALDH1A1 P00352 3/20 0.50
▸ PLA2G1B P04054 1/20 0.50
▸ ATG4B Q9Y4P1 1/20 0.50
▸ TNNI3 P19429 1/20 0.49
▸ TNNT2 P45379 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2741007 0.91 MEN1 (0.58) L3MBTL1PSMD14ALPLALPIALPG
SCHEMBL2740948 0.90 L3MBTL1 (0.55) L3MBTL1PSMD14ALPLALPIALPG
SCHEMBL2740986 0.89 MEN1 (0.56) L3MBTL1PSMD14ALPLALPIALPG
SCHEMBL2741006 0.88 MEN1 (0.55) L3MBTL1PSMD14ALPLALPIALPG
SCHEMBL2740994 0.87 L3MBTL1 (0.59) L3MBTL1PSMD14ALPLALPIALPG
SCHEMBL2740976 0.87 PSMD14 (0.53) L3MBTL1PSMD14ALPLALPIALPG
SCHEMBL2740972 0.84 MAPT (0.58) L3MBTL1PSMD14ALPLALPIALPG
SCHEMBL2740951 0.84 MEN1 (0.57) L3MBTL1PSMD14ALPLALPIALPG
SCHEMBL2740985 0.84 MEN1 (0.54) L3MBTL1PSMD14ALPLALPIALPG
SCHEMBL2741014 0.83 MEN1 (0.54) L3MBTL1PSMD14ALPLALPIALPG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8088772-B2 Sulfonamides and their use as a medicament THE GENETICS COMPANY, INC. (CH) 2012-01-03 — — US disclosed
Send feedback